Significant Ownership of Shay Capital LLC

Signature - Title
Elan Foxman - Chief Financial Officer
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Shay Capital LLC.

Follow Filing Activity

Follow Shay Capital LLC and return when a new Schedule 13D/G filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Significant Ownership of Shay Capital LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
TLYS Tilly's, Inc. Class A Common Stock, par value $0.001 per share 15% $4,983,300 +$974,986 3,390,000 +24% Shay Capital LLC 30 Jun 2025
LVTX LAVA Therapeutics NV Common shares, par value (euro) 0.12 per share 9.9% $3,972,497 2,596,403 Shay Capital LLC 19 Sep 2025
NEUP Neuphoria Therapeutics Inc. Common Stock, $0.00001 par value per share 7.3% $2,035,520 171,629 Shay Capital LLC 24 Oct 2025
RPTX Repare Therapeutics Inc. Common shares, no par value 6.7% $7,462,367 2,870,141 Shay Capital LLC 20 Jan 2026
OKUR OnKure Therapeutics, Inc. Class A Common Stock, par value $0.0001 per share 6.3% $2,057,944 810,214 Shay Capital LLC 15 May 2025
DMYY dMY Squared Technology Group, Inc. Class A Common Stock, par value $0.0001 per share 5.4% $1,738,729 125,359 Shay Capital LLC 26 Sep 2025
CTRN Citi Trends Inc Common stock, par value $0.01 5.1% $9,206,235 441,970 Shay Capital LLC 11 Apr 2025
NVRO Nevro Corp Common Stock, $0.001 par value per share 4.2% $9,179,090 1,571,762 Shay Capital LLC 31 Dec 2024
XELA Exela Technologies, Inc. Common Stock, Par Value $0.0001 per share 0.63% $87,800 175,600 Shay Capital LLC 31 Dec 2024

Schedules 13D/G Reported by Shay Capital LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored